Vanderbilt University Medical to Recruit Up to 1,000 COVID-19 Vaccine Trial Volunteers

 
Series: COVID-19 | Story 11


In late July, Vanderbilt University Medical Center (VUMC) will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

The randomized, placebo-controlled Phase 3 trial will be open to people 18 years old and older. They will receive two shots of either the vaccine or an inactive placebo and will be followed for two years.

The goals of the study are to determine how effe...



For access to this article please sign in or subscribe.

 

Reader Comments(0)

 
 

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2024

Rendered 03/26/2024 02:10